Hmdb loader
Survey
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 08:28:01 UTC
Update Date2021-09-26 23:03:01 UTC
HMDB IDHMDB0251161
Secondary Accession NumbersNone
Metabolite Identification
Common NameDibenzepin
DescriptionDibenzepin belongs to the class of organic compounds known as dibenzodiazepines. Dibenzodiazepines are compounds containing a dibenzodiazepine moiety, which consists of two benzene connected by diazepine ring. Due to this risk, TCAs are rarely selected as the first-line treatment for depression. Dibenzepin is a very strong basic compound (based on its pKa). Like other TCAs, dibenzepin may have potential use in the treatment of chronic neuropathic pain. Dibenzepin, sold under the brand name Noveril among others, is a tricyclic antidepressant (TCA) used widely throughout Europe for the treatment of depression. Dibenzepin is or was marketed mainly under the brand name Noveril. Dibenzepin was first introduced, in Switzerland and West Germany, in 1965. The drug has weak or negligible effects on serotonin and dopamine reuptake. This compound has been identified in human blood as reported by (PMID: 31557052 ). Dibenzepin is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Dibenzepin is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
Dibenzepin hydrochlorideMeSH
NoverilMeSH
Chemical FormulaC18H21N3O
Average Molecular Weight295.386
Monoisotopic Molecular Weight295.168462308
IUPAC Name9-[2-(dimethylamino)ethyl]-2-methyl-2,9-diazatricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,11,13-hexaen-10-one
Traditional Name9-[2-(dimethylamino)ethyl]-2-methyl-2,9-diazatricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,11,13-hexaen-10-one
CAS Registry NumberNot Available
SMILES
CN(C)CCN1C2=CC=CC=C2N(C)C2=CC=CC=C2C1=O
InChI Identifier
InChI=1S/C18H21N3O/c1-19(2)12-13-21-17-11-7-6-10-16(17)20(3)15-9-5-4-8-14(15)18(21)22/h4-11H,12-13H2,1-3H3
InChI KeyQPGGEKPRGVJKQB-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as dibenzodiazepines. Dibenzodiazepines are compounds containing a dibenzodiazepine moiety, which consists of two benzene connected by diazepine ring.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassBenzodiazepines
Sub ClassDibenzodiazepines
Direct ParentDibenzodiazepines
Alternative Parents
Substituents
  • Dibenzodiazepine
  • Alkyldiarylamine
  • 1,4-benzodiazepine
  • Tertiary aliphatic/aromatic amine
  • Para-diazepine
  • Benzenoid
  • Tertiary carboxylic acid amide
  • Vinylogous amide
  • Tertiary aliphatic amine
  • Tertiary amine
  • Lactam
  • Carboxamide group
  • Amino acid or derivatives
  • Carboxylic acid derivative
  • Azacycle
  • Amine
  • Organic oxide
  • Organic nitrogen compound
  • Organopnictogen compound
  • Organooxygen compound
  • Organonitrogen compound
  • Organic oxygen compound
  • Hydrocarbon derivative
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP2.33ALOGPS
logP2.64ChemAxon
logS-2.4ALOGPS
pKa (Strongest Basic)8.23ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area26.79 ŲChemAxon
Rotatable Bond Count3ChemAxon
Refractivity90.05 m³·mol⁻¹ChemAxon
Polarizability33.4 ųChemAxon
Number of Rings3ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+163.8430932474
DeepCCS[M-H]-161.48230932474
DeepCCS[M-2H]-194.36830932474
DeepCCS[M+Na]+169.93330932474
AllCCS[M+H]+169.832859911
AllCCS[M+H-H2O]+166.432859911
AllCCS[M+NH4]+173.032859911
AllCCS[M+Na]+173.932859911
AllCCS[M-H]-176.632859911
AllCCS[M+Na-2H]-176.232859911
AllCCS[M+HCOO]-176.032859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
DibenzepinCN(C)CCN1C2=CC=CC=C2N(C)C2=CC=CC=C2C1=O3492.9Standard polar33892256
DibenzepinCN(C)CCN1C2=CC=CC=C2N(C)C2=CC=CC=C2C1=O2481.5Standard non polar33892256
DibenzepinCN(C)CCN1C2=CC=CC=C2N(C)C2=CC=CC=C2C1=O2377.2Semi standard non polar33892256
Spectra
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB13225
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkDibenzepin
METLIN IDNot Available
PubChem Compound9419
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]